feed,title,long_url,short_url
SeekingAlpha,Spruce Biosciences Proposes $75 Million IPO Terms,https://seekingalpha.com/article/4377883,
SeekingAlpha,Orphazyme: Recent Weakness Presents A Buying Opportunity,https://seekingalpha.com/article/4377880,
